Literature DB >> 9242368

Menstrual cycle-associated changes in blood levels of interleukin-6, alpha1 acid glycoprotein, and C-reactive protein.

B Jilma1, E Dirnberger, I Löscher, A Rumplmayr, J Hildebrandt, H G Eichler, S Kapiotis, O F Wagner.   

Abstract

Based on previous studies we hypothesized that interleukin-6 (IL-6) plasma levels would increase during the menstrual cycle, in analogy to the increase in IL-1 levels seen during the luteal phase. Thus we have investigated menstrual cycle-associated changes in IL-6, alpha1 acid glycoprotein (AGP), and C-reactive protein (CRP). The study design was cross-sectional and was conducted in 18 healthy premenopausal women with regular menstrual cycles and in 15 age-matched men. The women had blood drawings in the follicular phase, at midcycle, and in the luteal phase of the menstrual cycle. A single blood sample was obtained from men to compare IL-6 levels between sexes. The median IL-6 level was 0.68 pg/ml (95% confidence interval (CI): 0.60 to 1.05) in the follicular phase and did not change significantly during the menstrual cycle. IL-6 levels did not differ between women and men (0.79 pg/ml; CI: 0.66 to 1.05; p > 0.05). Median AGP levels decreased by 6% (CI: -14% to 1%) during the luteal phase (p = 0.005), and a significant correlation between mean AGP and IL-6 levels was found (r = 0.60; p = 0.01). Median CRP levels increased by 44% (CI: 27% to 59%; p < 0.001) at midcycle and by 31% (CI: 17% to 68%; p = 0.002) in the luteal phase, and there was a significant correlation between the relative increase in CRP at midcycle and the relative increase in progesterone levels during midcycle (r = 0.60; p = 0.01) and the luteal phase (r = 0.71; p = 0.001). In conclusion, we found no sustained menstrual cycle-dependent changes in systemic IL-6 plasma levels. AGP and CRP levels may be differentially regulated during the menstrual cycle of healthy women: AGP levels correlated with IL-6 levels, and AGP levels decreased during the menstrual cycle, whereas CRP levels increased during the menstrual cycle and correlated with the increase in progesterone levels. The reason for the observed changes in CRP levels remains to be elucidated.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9242368     DOI: 10.1016/s0022-2143(97)90060-3

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  30 in total

1.  Reference distributions for serum iron and transferrin saturation: a practical, simple, and clinically relevant approach in a large cohort.

Authors:  Robert F Ritchie; Glenn E Palomaki; Louis M Neveux; Olga Navolotskaia; Thomas B Ledue; Wendy Y Craig
Journal:  J Clin Lab Anal       Date:  2002       Impact factor: 2.352

2.  Endogenous reproductive hormones and C-reactive protein across the menstrual cycle: the BioCycle Study.

Authors:  Audrey J Gaskins; Machelle Wilchesky; Sunni L Mumford; Brian W Whitcomb; Richard W Browne; Jean Wactawski-Wende; Neil J Perkins; Enrique F Schisterman
Journal:  Am J Epidemiol       Date:  2012-02-03       Impact factor: 4.897

3.  The effect of high-intensity aerobic interval training on markers of systemic inflammation in sedentary populations.

Authors:  Nicholas G Allen; Samuel M Higham; Amy E Mendham; Tegan E Kastelein; Penelope S Larsen; Rob Duffield
Journal:  Eur J Appl Physiol       Date:  2017-04-13       Impact factor: 3.078

Review 4.  Failure to consider the menstrual cycle phase may cause misinterpretation of clinical and research findings of cardiometabolic biomarkers in premenopausal women.

Authors:  Enrique F Schisterman; Sunni L Mumford; Lindsey A Sjaarda
Journal:  Epidemiol Rev       Date:  2013-09-15       Impact factor: 6.222

5.  A Prospective Study of Variability in Glycemic Control during Different Phases of the Menstrual Cycle in Type 2 Diabetic Women Using High Sensitivity C - Reactive Protein.

Authors:  T S Gugapriya; S Karthick; B Nagarjuna
Journal:  J Clin Diagn Res       Date:  2014-04-15

6.  Association of endogenous hormones with C-reactive protein, fibrinogen, and white blood count in post-menopausal women.

Authors:  Aaron R Folsom; Sherita Hill Golden; Lori L Boland; Moyses Szklo
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

7.  Reference distributions for the positive acute phase serum proteins, alpha1-acid glycoprotein (orosomucoid), alpha1-antitrypsin, and haptoglobin: a practical, simple, and clinically relevant approach in a large cohort.

Authors:  R F Ritchie; G E Palomaki; L M Neveux; O Navolotskaia; T B Ledue; W Y Craig
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

8.  Targeted and restricted complement activation on acrosome-reacted spermatozoa.

Authors:  Rebecca C Riley-Vargas; Susan Lanzendorf; John P Atkinson
Journal:  J Clin Invest       Date:  2005-04-21       Impact factor: 14.808

9.  Urinary cytokine and chemokine profiles across the menstrual cycle in healthy reproductive-aged women.

Authors:  Brian W Whitcomb; Sunni L Mumford; Neil J Perkins; Jean Wactawski-Wende; Elizabeth R Bertone-Johnson; Kristine E Lynch; Enrique F Schisterman
Journal:  Fertil Steril       Date:  2014-02-26       Impact factor: 7.329

10.  To assess, to control, to exclude: effects of biobehavioral factors on circulating inflammatory markers.

Authors:  Mary-Frances O'Connor; Julie E Bower; Hyong Jin Cho; J David Creswell; Stoyan Dimitrov; Mary E Hamby; Michael A Hoyt; Jennifer L Martin; Theodore F Robles; Erica K Sloan; Kamala S Thomas; Michael R Irwin
Journal:  Brain Behav Immun       Date:  2009-04-21       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.